Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

“If only we had the data…” key questions in oncology antibody development

David S. Young, Helen P. Findlay, Luis A G Da Cruz, Susan E. Hahn

Cancer Res (2006) 66 (8_Supplement): 281.

Published: 15 April 2006

View article

Journal Articles

Antibodies targeting the tumor-associated antigen TROP-2 demonstrate anti-tumor effects in human pancreatic cancer models

Susan E. Hahn, Luis A G Da Cruz, Daad Sayegh, Kristian J. Rogers, Victor Saldivia, Valerie Harris, Lisa Cechetto, David S. Young

Cancer Res (2006) 66 (8_Supplement): 877.

Published: 15 April 2006

View article

Journal Articles

AR53A10.11 and AR58A314.1, 2 ARIUS functional monoclonal antibodies target tumor specific antigens

Daad A. Sayegh, Mitra Amoozgar, Fortunata McConkey, Nives Ceric, Susan E. Hahn, Helen Findlay, David S. Young

Cancer Res (2006) 66 (8_Supplement): 151.

Published: 15 April 2006

View article

Journal Articles

Towards enabling personalized cancer drug therapy: Functional monoclonal antibodies target overlapping populations of human breast cancer and melanoma

Daad Sayegh, Susan E. Hahn, Cechetto Lisa, Alison Ferry, Lisa Popp, Helen Findlay, David S. Young

Cancer Res (2005) 65 (9_Supplement): 163–164.

Published: 01 May 2005

View article

Journal Articles

Characterization of a hepatocellular carcinoma-specific antibody AR5LAC-23

Michelle Kelleher, Fortunata McConkey, Andrea J. Warner, Noel Drury, Susan E. Hahn, Miles W. Carroll, Stuart Naylor, Helen P. Findlay, David S. Young

Cancer Res (2005) 65 (9_Supplement): 1213.

Published: 01 May 2005

View article

Journal Articles

Three unique antibodies demonstrate therapeutic effects against CD63, a novel target for cancer therapy

Susan E. Hahn, Victor Saldivia, Daad Sayegh, Huma Ahmad, Lisa Cechetto, Luis A. G. Da Cruz, David S. Young

Cancer Res (2005) 65 (9_Supplement): 549.

Published: 01 May 2005

View article

Journal Articles

Drugs versus targets (the chicken or the egg): Discovery of functional anti-cancer antibodies using a non-target driven approach.

David S. Young, Lisa M. Cechetto, Susan E. Hahn, Helen P. Findlay

Cancer Res (2004) 64 (7_Supplement): 709.

Published: 01 April 2004

View article

NARROW

“If only we had the data…” key questions in oncology antibody development

Antibodies targeting the tumor-associated antigen TROP-2 demonstrate anti-tumor effects in human pancreatic cancer models

AR53A10.11 and AR58A314.1, 2 ARIUS functional monoclonal antibodies target tumor specific antigens

Towards enabling personalized cancer drug therapy: Functional monoclonal antibodies target overlapping populations of human breast cancer and melanoma

Characterization of a hepatocellular carcinoma-specific antibody AR5LAC-23

Three unique antibodies demonstrate therapeutic effects against CD63, a novel target for cancer therapy

Drugs versus targets (the chicken or the egg): Discovery of functional anti-cancer antibodies using a non-target driven approach.

Email alerts

AACR Journals

“If only we had the data…” key questions in oncology antibody development

Antibodies targeting the tumor-associated antigen TROP-2 demonstrate anti-tumor effects in human pancreatic cancer models

AR53A10.11 and AR58A314.1, 2 ARIUS functional monoclonal antibodies target tumor specific antigens

Towards enabling personalized cancer drug therapy: Functional monoclonal antibodies target overlapping populations of human breast cancer and melanoma

Characterization of a hepatocellular carcinoma-specific antibody AR5LAC-23

Three unique antibodies demonstrate therapeutic effects against CD63, a novel target for cancer therapy

Drugs versus targets (the chicken or the egg): Discovery of functional anti-cancer antibodies using a non-target driven approach.

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only